Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: A cross-sectional survey

Journal of Alzheimer's Disease

Volumn 33, Issue 3, 2013, Pages 853-862

  Kim, Ggotpin ^a   Kim, Hyesook ^a   Kim, Ki Nam ^b   Son, Jung In ^c   Kim, Seong Yoon ^c   Tamura, Tsunenobu ^a,d   Chang, Namsoo ^a  

^a Ewha Womans University   (South Korea)

^b Daejeon University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alzheimer's disease; cognitive function; folate; homocysteine; mild cognitive impairment; tissue factor pathway inhibitor; vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; TISSUE FACTOR PATHWAY INHIBITOR;

AGED; ARTICLE; BOSTON NAMING; CALORIC INTAKE; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; CONSTRUCTIONAL RECALL TESTS; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GERIATRIC PATIENT; HEALTH BEHAVIOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; VITAMIN BLOOD LEVEL; WORD LIST RECALL;

EID: 84872435778     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121345     Document Type: Article

References (50)

1. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82, 636-643.
2. Regland B, Abrahamsson L, Gottfries CG, Magnus E (1990) Vitamin B12 analogues, homocysteine, methylmalonic acid, and transcobalamins in the study of vitamin B12 deficiency in primary degenerative dementia. Dement Geriatr Cogn Disord 1, 272-277.
3. Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Rumble RL, Szoeke C, Taddei K, Taddei T, Trounson BO, Villemagne VL, Ward V, Ames D, Masters CL, Bush AI (2011) Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: Baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle Study. J Alzheimers Dis 27, 909-922.
4. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80, 114-122. (Pubitemid 41115564)
5. Riggs KM, Spiro A 3rd, Tucker K, Rush D (1996) Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 63, 306-314. (Pubitemid 26074688)
6. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, Allen LH, Green R (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511-517. (Pubitemid 46220956)
7. Hooshmand B, Solomon A,K°areholt I, Rusanen M,H?anninen T, Leivisk?a J, Winblad B, Laatikainen T, Soininen H, Kivipelto M (2012) Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: A longitudinal study. J Intern Med 271, 204-212.
8. Selley ML, Close DR, Stern SE (Aging) (2002) The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol 23, 383-388. (Pubitemid 34312021)
9. Fuso A, Seminara L, Cavallaro RA, D'Anselmi F, Scarpa S (2005) Sadenosylmethionine/homocysteine cycle alterations modifyDNAmethylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 28, 195-204. (Pubitemid 39656023)
10. Piazza F, Galimberti G, Conti E, Isella V, Perlangeli MV, Speranza T, Borroni B, Pogliani EM, Padovani A, Ferrarese C (2012) Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease. Neurobiol Aging 33, 226-233.
11. Zhuo JM, Portugal GS, Kruger WD, Wang H, Gould TJ, Pratico D (2010) Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. Curr Alzheimer Res 7, 140-149.
12. Hollister RD, Kisiel W, Hyman BT (1996) Immunohistochemical localization of tissue factor pathway inhibitor-1(TFPI-1), a Kunitz proteinase inhibitor, in Alzheimer's disease. Brain Res 728, 13-19. (Pubitemid 26254951)
13. Cho SY, Kim SB, Lee MS, Kim HJ, Yun J, Kim K, Choi KG, Choi BO (2006) Association between elevated homocysteine concentration and Alzheimer's disease, vascular disease, and mild cognitive impairment [Korean]. J Korean Neurol Assoc 24, 231-238.
14. Lee JH, Lee KJ,KimHJ (2010) Serum levels of homocysteine, folate, and vitamin B12 and cognitive function in mild cognitive impairment and Alzheimer's disease [Korean]. Korean Geriatr Psychiatry 14, 44-49.
15. Kim HJ, Kim H, Kim KN, Kim G, Son JI, Kim SY, Chang N (2008) Relationship of plasma homocysteine, folate, vitamin B12 and nutrient intakes with neurocognitive function in elderly [Korean]. Korean J Nutr 41, 439-447.
16. Kim J, Park MH, Kim E, Han C, Jo SA, Jo I (2007) Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderlyKorean population. J Nutr 137, 2093-2097. (Pubitemid 47367271)
17. Lee DY, Lee JH, Ju YS, Lee KU, Kim KW, Jhoo JH, Yoon JC, Ha J, Woo JI (2002) The prevalence of dementia in older people in an urban population of Korea: The Seoul study. J Am Geriatr Soc 50, 1233-1239. (Pubitemid 34774547)
18. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A (1998) Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147, 574-580. (Pubitemid 28134244)
19. Choi SH, Kim S, Han SH, Na DL, Kim DK, Cheong HK, Lee JH, Kim SY, Hong CH, Moon SY, Kwon JC, Kim JE, Jeong JH, Na HR, Cha KR, Seo SW, Shim YS, Lee JY, Park KW (2012) Neurologic signs in relation to cognitive function in subcortical ischemic vascular dementia:ACREDOS(Clinical Research Center for Dementia of South Korea) study. Neurol Sci 33, 839-846.
20. Woo EK, Han C, Jo SA, Park MK, Kim S, Kim E, Park MH, Lee J, Jo I (2007) Morbidity and related factors among elderly people in South Korea: Results from the Ansan Geriatric (AGE) cohort study. BMC Public Health 7, 10.
21. KimKW, Park JH, Kim MH, Kim MD, Kim BJ, Kim SK, Kim JL, MoonSW, Bae JN,Woo JI, Ryu SH,Yoon JC, Lee NJ, Lee DY, LeeDW, Lee SB, Lee JJ, Lee JY, Lee CU, Chang SM, Jhoo JH, Cho MJ (2011) A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea. J Alzheimers Dis 23, 281-291.
22. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, Lee KH, Kim SY, Han SH, Woo JI (2002) Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): Clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 57, P47-P53. (Pubitemid 34052886)
23. Lee DY, Lee KU, Lee JH, Kim KW, Jhoo JH, Kim SY, Yoon JC, Woo SI, Ha J, Woo JI (2004) A normative study of the CERADneuropsychological assessment battery in theKorean elderly. J Int Neuropsychol Soc 10, 72-81. (Pubitemid 38128464)
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
25. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
26. Feng L, Ng TP, Chuah L, Niti M, Kua EH (2006) Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: Findings from the Singapore Longitudinal Ageing Study. Am J Clin Nutr 84, 1506-1512. (Pubitemid 44912837)
27. Kageyama M, Hiraoka M, Kagawa Y (2008) Relationship between genetic polymorphism, serum folate and homocysteine in Alzheimer's disease. Asia Pac J Public Health 20Suppl, 111-117.
28. Bi XH, Zhao HL, Zhang ZX, Liu Q, Zhang JW (2010) Association analysis of CbetaS 844ins68 and MTHFD1 G1958A polymorphisms with Alzheimer's disease in Chinese. J Neural Transm 117, 499-503.
29. Ravaglia G, Forti P, Maioli F, Vettori C, Grossi G, Bargossi AM, Caldarera M, Franceschi C, Facchini A, Mariani E, CavalliG(2000) Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mech Ageing Dev 121, 251-261. (Pubitemid 32115418)
30. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM (1999) Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. Am J Epidemiol 150, 283-289. (Pubitemid 29344955)
31. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22, 1752-1762. (Pubitemid 35386293)
32. Religa D, Styczynska M, Peplonska B, Gabryelewicz T, Pfeffer A, Chodakowska M, Luczywek E, Wasiak B, Stepien K, Golebiowski M, Winblad B, Barcikowska M (2003) Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 16, 64-70. (Pubitemid 36677098)
33. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM(1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55, 1449-1455. (Pubitemid 28525506)
34. Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Widner B, Reibnegger G, Fuchs D (2000) Hyperhomocysteinemia in dementia. J Neural Transm 107, 1469-1474. (Pubitemid 32049942)
35. Levitt AJ, Karlinsky H (1992) Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatr Scand 86, 301-305.
36. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH,Wilkinson C (2001) Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 12, 309-313. (Pubitemid 32656662)
37. Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, Breteler MM (2002) Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study. Neurology 59, 1375-1380. (Pubitemid 35285990)
38. Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Jacques PF, Selhub J, Seshadri S, Au R, Beiser A, Wolf PA (2005) Homocysteine and cognitive performance in the Framingham offspring study: Age is important. Am J Epidemiol 162, 644-653. (Pubitemid 41437363)
39. Morris MS, Jacques PF, Rosenberg IH, Selhub J, National Health and Nutrition Examination Survey (2001) Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 73, 927-933. (Pubitemid 32405990)
40. Chang N, Kim E, Kim KN, Kim H, Kim SY, Jeong BS (2009) Folate nutrition is related to neuropsychological functions in the elderly. Nutr Res Pract 3, 43-48.
41. Bertsch T, Mielke O, H?oly S, Zimmer W, Casarin W, Aufenanger J, Walter S, Muehlhauser F, Kuehl S, Ragoschke A, Fassbender K (2001) Homocysteine in cerebrovascular disease: An independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med 39, 721-724. (Pubitemid 32894418)
42. Yamada M, Mimori Y, Kasagi F, Miyachi T, Ohshita T, Sudoh S, Ikeda J, Matsui K, Nakamura S, Matsumoto M, Fujiwara S, Sasaki H (2008) Incidence of dementia, Alzheimer disease, and vascular dementia in a Japanese population: Radiation Effects Research Foundation adult health study. Neuroepidemiology 30, 152-160. (Pubitemid 351667795)
43. Herrmann W, Knapp JP (2002) Hyperhomocysteinemia: A new risk factor for degenerative diseases. Clin Lab 48, 471-481. (Pubitemid 35174963)
44. Bertsch T, Mielke O, H?oly S, Zimmer W, Casarin W, Aufenanger J, Walter S, Muehlhauser F, Kuehl S, Ragoschke A, Fassbender K (2001) Homocysteine in cerebrovascular disease: An independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med 39, 721-724. (Pubitemid 32894418)
45. Bell RD (2012) The imbalance of vascular molecules in Alzheimer's disease. J Alzheimers Dis; e-pub ahead of print 31 July 2012.
46. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenh?ager WH (2002) Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 162, 2046-2052. (Pubitemid 35168212)
47. L?uders S, St?ove S, Schrader J (2012) Prevention of vascular dementia. Evidence and practice [German]. Internist (Berl) 53, 223-231.
48. de laTorre JC (2010)Vascular risk factor detection and control may prevent Alzheimer's disease. Ageing Res Rev 9, 218-225.
49. Kwak YT, Yang Y, Kim GW (2010) Korean Addenbrooke's Cognitive Examination Revised (K-ACER) for differential diagnosis of Alzheimer's disease and subcortical ischemic vascular dementia. Geriatr Gerontol Int 10, 295-301.
50. Rom'an GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1, 426-436. (Pubitemid 37159153)